What Optura does
Optura built a platform called ROAI (Return on AI Investment) that helps healthcare payers and providers measure the business value of their AI deployments. The platform maps organizational data into a unified knowledge layer, scores and prioritizes AI use cases, turns workflows into AI agents, and tracks real-time impact against expected returns. Customers include enterprise health plans and providers such as Independence Blue Cross, Prime Therapeutics, and Ardent Health, according to the company. Optura says more than $2 billion of AI initiatives are currently tracked on its platform.
Optura is a healthcare tool on Falcoscan. Enterprise platform that measures healthcare organizations' return on AI investment. Falcoscan rates Optura with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Optura is founded in 2024, currently at Series_a stage. Pricing: Paid.